Major classes of neutralizing antibodies evaded by the SARS-CoV-2 Omicron variant
Description
Understanding how SARS-CoV-2 evades neutralizing antibodies is crucial for the development of therapeutic antibodies and universal vaccines. In this issue of Structure, Patel et al. elucidate mechanisms of SARS-CoV-2 escape from two major antibody
